XOMA Royalty (XOMA) Total Debt Growth (3y) (2013 - 2024)
XOMA Royalty (XOMA) Total Debt Growth (3y) (2013 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 50.25% |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 25.25% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 85.66% |
| Dec 31, 2023 | 81.20% |
| Mar 31, 2021 | 8.97% |
| Dec 31, 2020 | 12.69% |
| Sep 30, 2020 | 27.95% |
| Jun 30, 2020 | 3.73% |
| Mar 31, 2020 | 5.79% |
| Dec 31, 2019 | -9.24% |
| Sep 30, 2019 | -10.26% |
| Jun 30, 2019 | -17.61% |
| Mar 31, 2019 | -21.26% |
| Dec 31, 2018 | -22.70% |
| Sep 30, 2018 | -23.17% |
| Jun 30, 2018 | -32.36% |
| Mar 31, 2018 | -32.41% |
| Dec 31, 2017 | -25.55% |
| Sep 30, 2017 | -26.88% |
| Jun 30, 2017 | -10.06% |
| Mar 31, 2017 | -11.75% |
| Dec 31, 2016 | 1.74% |